---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-123322"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:16:39.428635+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RxSight Q3 revenue $35.3M (+59% YoY); raises FY revenue guidance to $139-140M

## Summary
- Revenue $35.3M, up 59% YoY; LAL procedures 24,554 (+80%), LDD installed base 888 (+51%).
- Gross margin 71.4% vs 61.9% YoY; net loss narrowed to $6.3M ($0.16/sh) from $12.4M ($0.35/sh).
- Adjusted net earnings $214K ($0.00/diluted) vs adjusted loss $6.9M ($0.19/sh) a year ago.
- FY2024 revenue guidance raised to $139-140M top of prior range; gross margin guided 70-71% (up from 68-70%).
- Cash & equivalents $237.1M at Sept 30, 2024 vs $233.3M at June 30, 2024.

## SEC filing metadata
- accession: 0000950170-24-123322
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017024123322/0000950170-24-123322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017024123322/rxst-20241107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-123322
- JSON: https://secwatch.observer/filing/0000950170-24-123322.json
- Plain text: https://secwatch.observer/filing/0000950170-24-123322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.